InvestorsHub Logo
Followers 5
Posts 557
Boards Moderated 0
Alias Born 06/23/2015

Re: jimmy667 post# 75588

Wednesday, 09/21/2016 9:39:23 AM

Wednesday, September 21, 2016 9:39:23 AM

Post# of 463351
My point was to show that apparantly Tobira was hyped just as Anavex was (and also sued), but that nothing is impossible for a clinical stage bio company with no drugs approved. What is unusual about the Tobira deal is that Allergan pays a huge premium.

Let's hope that Anavex will deliver.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News